Newbury Park, CA, United States of America

John Gordon Allen

This inventor holds 29 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in Cancer Therapeutics. Top assignees: Amgen Inc., Eli Lilly and Company. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Gordon Allen. Retrieved from https://idiyas.com/inventor/john-gordon-allen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 14)

% Patents Active = 72.4

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 15 (Patent Applications = 14)

Average Co-Inventor Count = 11.9

ph-index = 8

Forward Citations = 203(Granted Patents)

Location History:

Newbary Park, CA (US) (2013)
Newbury Park, CA (US) (2009 - 2024)
Thousand Oaks, CA (US) (2016 - 2024)

Company Filing History:

Eli Lilly and Company

patents

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

KRAS G12C Inhibitors

RNAi Constructs

Apelin Polypeptides

KIF18A Inhibitors

Thiazole Compounds

Piperazines

Carbohydrate Phosphonates

Thiadiazole Modulators

Heterocyclic Modulators

Pyrrolidinones

Cycloalkyl Lactams

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723248 - RNAi constructs for inhibiting ASGR1 expression and methods of use thereof (2026-09-01),

2. 12679868 - Apelin polypeptides (2026-07-14),

3. 12540129 - KIF18A inhibitors (2026-02-03),

4. 12459932 - KIF18A inhibitors (2025-11-04),

5. 12441736 - KIF18A inhibitors (2025-10-14),

6. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),

7. 12435058 - KIF18A inhibitors (2025-10-07),

8. 12083121 - Substituted piperazines as KRAS G12C inhibitors (2024-09-10),

9. 11905281 - KRAS G12C inhibitors and methods of using the same (2024-02-20),

10. 11807693 - Apelin polypeptides (2023-11-07),

11. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),

12. 11732266 - RNAi constructs for inhibiting ASGR1 expression and methods of use thereof (2023-08-22),

13. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),

14. 11096939 - KRAS G12C inhibitors and methods of using the same (2021-08-24),

15. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),

Title: The Innovative Journey of John Gordon Allen

Introduction: John Gordon Allen, a visionary inventor based in Newbury Park, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: John Gordon Allen holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, John Gordon Allen has established himself as a prominent figure in the world of innovation. His work has not only revolutionized existing industries but has also paved the way for new technological advancements.

Collaborations: Throughout his career, John Gordon Allen has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development of cutting-edge technologies.

Conclusion: John Gordon Allen's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his position as a respected inventor in the technological landscape. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.